Safety of live attenuated varicella-zoster vaccine in patients with underlying illnesses compared with healthy adults: a prospective cohort study
Abstract Background In Japan, freeze-dried live attenuated varicella-zoster vaccine is available for adults aged ≥50 years to prevent herpes zoster. However, limited evidence has been accumulated regarding vaccine safety for patients with underlying illnesses, who have been considered as the high-ri...
Main Authors: | Satoko Ohfuji, Kazuya Ito, Megumi Inoue, Motoki Ishibashi, Hiroko Kumashiro, Yoshio Hirota, Eiji Kayano, Naoshi Ota |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-019-3719-7 |
Similar Items
-
Herpes zoster ophthalmicus and varicella zoster virus vasculopathy
by: Francisco Bandeira, et al.
Published: (2016-04-01) -
Etymologia: Varicella Zoster Virus
Published: (2015-04-01) -
Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation
by: Tetsuko Sato, et al.
Published: (2021-02-01) -
Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands
by: Pierik Jorien GJ, et al.
Published: (2012-05-01) -
An adult co-presented with varicella and herpes zoster caused by varicella zoster virus genotype J, China: a case report
by: Guangcheng Xie, et al.
Published: (2020-06-01)